Special Free Report From The Motley Fool

IPH Limited (IPH),

Company snapshot

Recent price: $4.77 (as at 15/06/2017)

Market cap: $920 million

Cash/debt: $32 million / $0 million

P/E ratio: 18.1 (trailing 12 months)

Dividend yield: 4.5% Partially franked (trailing 12 months)

Why Buy?

  • High recurring cash flows
  • Rock solid balance sheet
  • Attractive growth potential

IPH Limited, ASX:IPH, is a legal firm specialising in Intellectual Property (IP). Specifically, it helps its clients pursue patent and trademark protections, and then helps monitor, enforce and renew those protections. Although IPH is a newcomer to the ASX, having listed only in late 2014, it has a long and successful history, with the origins of the business dating back to 1887 when the original “Hepburn & Spruson” partnership was formed.

Lots To Like

Unlike many services based firms, IPH enjoys a good deal of recurring sales. The business earns money throughout the entire patent and trademark process, which is a lengthy one — for example, it takes anywhere between two and five years just for a patent to be granted. Moreover, after that point the management and enforcement of IP protections provides for an attractive annuity-like revenue stream.

The business is not overly exposed to any one client either, with over 3,000 active clients spread across a range of industries. The largest client accounts for less than 3% of sales.

IPH is also a great fit for those looking for offshore exposure. Clients are typically Fortune Global 500 companies and other significant multinationals that are seeking expansion into the Asia pacific region. 70% of revenue is sourced internationally, with the majority of invoices being billed in US dollars.

The company is also well placed to make bolt-on acquisitions, given it has a large pile of cash, untapped debt facilities and zero debt. Moreover, acquired businesses can leverage off existing assets and resources, thereby becoming more efficient as part of a larger group.

Dividends A’hoy!

As a relative newcomer to the ASX, we don’t have a lot of dividend history to draw on — though what we do have is encouraging.

At the current price, shares are yielding a very decent 4.5%, which is a good deal higher than the current market average and particularly attractive in the current low interest rate world. Due to its offshore earnings, IPH doesn’t always offer full franking, but distributions to date have averaged a franking rate of 70%. Grossing the yield up at this level improves the yield to a juicy 5.8%.

And, because IPH has a very low capital requirement (that is, it doesn’t need to retain much cash to operate and grow the business), shareholders can expect a majority of profit to paid out each year. Couple that with the expectation for above average earnings growth, and we think the long term income potential looks especially attractive.

Risks And When We’d Sell

Acquisitions can be a great way to juice earnings, but shareholders don’t always benefit if the company overpays, or buys a dud. Also, given these are ‘people businesses’, there’s the risk that key people may leave and take valuable clients with them. It’s an area to watch.

With most work billed is US dollars, we must also be mindful of exchange rates. Should the Aussie dollar see a material and sustained strengthening, that would dampen growth.

Finally, though not a risk per se, we are mindful that shares are — to a certain extent — priced for growth. If per-share earnings grow at a lower than expected rate, a market revaluation could give the share price a knock.

The Foolish Bottom Line

IPH is a well established business with a clear and proven strategy, as well as a long runway of growth. And, because the business requires little capital to sustain operations, a high proportion of earnings are able to be distributed to shareholders in the form of lovely cash dividends.

With a favourable industry tailwind, leading market position and super-strong balance sheet, we think it could be the perfect addition to any income focused portfolio.

Now here’s what you might call the really big news…

Want even more dividend ideas? Claim your RISK-FREE TRIAL of Motley Fool Dividend Investor now

As you may know, The Motley Fool runs what is arguably Australia’s most popular dividend-investing service…

It’s called Motley Fool Dividend Investor. And it’s led to investors just like you landing winners such as…

  • Australian Pharmaceutical Industries (API)… up 133.9%
  • Altium (ALU)… up 112.3%
  • Event Hospitality & Entertainment (EVT)… up 62.8%

Not to mention one company paying a full 8% yield… and two more paying over 7%

So I expect you’re eager to hear how you can see every single BUY recommendation.

In fact, I’m happy to extend you an invitation to join us right now, taking a full 30 days to review everything Dividend Investor has to offer you.

It’s only fair. Then you can decide for yourself if Motley Fool Dividend Investor is right for you.

So, in a moment, I’ll show you how to claim your risk-free trial. It’s simple and easy, and won’t take but a few minutes of your time.

But first, allow me a proper introduction – and let me fill you in on why I’ve committed $100,000 of my own family’s money to following Dividend Investor

My name is Bruce Jackson, and I’m the General Manager of The Motley Fool Australia.

Though I’ve been eating and breathing the share market for more than two decades…

It wasn’t until October 2014 that I made one of the single biggest bets of my investing career…Electing to put $100,000 of my family’s own money into some of the Motley Fool Dividend Investor stock picks.

All for two simple reasons:

1. I believe Andrew Page, our Motley Fool Dividend Investor lead advisor, is one of the most capable income-focused experts working in Australia today. (And with picks like Australian Pharmaceutical Industries, up 133.9%… and Altium, up 112.3%… all in just over two years’ time, he’s got the track record to prove it.)

2. I’m so convinced of the income AND growth potential of his Motley Fool Dividend Investor picks, I wanted to be sure I didn’t miss out!

Make no mistake. Motley Fool Dividend Investor is, in my opinion, the absolute BEST decision for any investor seeking the lucrative intersection of steady, robust dividend yield and long-term capital appreciation potential in today’s tricky market.

With one exceptional monthly dividend stock pick at a time, this service WILL likely make you money for decades to come.

That’s why I want to invite you to get in on this tremendous wealth-building adventure today…

So you can start enjoying these exclusive benefits of membership right now:

    • One new dividend pick each month – with every single stock a high-conviction dividend play—delivered to your inbox like clockwork, month in and month out.
    • Exclusive access to our members-only website, where you’ll find our “Buy First” stocks and every other Motley Fool Dividend Investor stock pick we’ve ever recommended. Plus, over time, a number of “for your eyes only” interviews, videos, and articles.
    • An online scorecard that lets you see the performance of ALL our stock tips, including dividend yields, in one convenient place.
    • Breaking alerts by email with important market news that impacts your portfolio, including weekly updates on our picks.
    • 24/7 access to our exclusive member-only online discussion boards.

AND AS A SPECIAL BONUS GIFT, when you join us today, I’ll even send you a FREE copy of my brand-new report, “3 Overlooked Small-Cap Shares with Big Dividend Yields.” All so you can start investing the Dividend Investor way the moment you join us!

And did I mention your RISK-FREE trial?

If you act right now, you can lock in a one year of membership to Motley Fool Dividend Investor for just $99…

That’s a whopping 50% OFF our retail price. Click here now to secure your subscription at this low, low price.

Meanwhile, you can rest assured you’re 100% protected by our 30-day, no questions asked, money-back guarantee of your subscription fee.

That’s right. You’re entitled to take a FULL 30 DAYS to have a good look at everything Motley Fool Dividend Investor has to offer.

In other words, you have the chance to see every recommendation ever made inside Dividend Investor – names, codes, the full investment analysis for each…

AND see for yourself what Dividend Investor members really think of the service, with ‘no holds barred’ discussion on our proprietary message boards…

And even keep your copy of my brand-new report, “3 Overlooked Small-Cap Shares with Big Dividend Yields”

Then get all your money back if you so choose. (It’s true. We consider this ‘fair use’ of our Motley Fool membership-fee guarantee.)

All you’d have to do is let our friendly customer service team know, by phone or email, that you’d like to cancel… any time within your first 30 days.

You’ll receive every cent back. No hassle, no fuss.

But there is just one catch…


If you’d like to take advantage of this very special offer, we need to hear from you right away!

Your risk-free trial of Motley Fool Dividend Investor is available for just a short time – blink and you could miss it.

So be sure to click the link below to unlock your risk-free trial right now.

Click here Now to Start Your Risk-Free Trial of Motley Fool Dividend Investor

I look forward to welcoming you as a brand-new member,

Bruce Jackson

Bruce Jackson
General Manager, Motley Fool Australia

P.S. Keep in mind: This RISK-FREE TRIAL lets you sample everything Dividend Investor has to offer and potentially pay nothing at all! And if you do decide to stay on as a member… you’ll enjoy a full 50% OFF the usual price! So you’re only right to call this a ‘win-win’… Simply click here to get started.

IPH Returns last updated: 15 June 2017
DI Scorecard returns last updated 26 June 2017

This report was prepared by Andrew Page, and authorised by Bruce Jackson. This report contains general investment advice only (under AFSL 400691). Please refer to our Financial Services Guide (FSG) for more information. The Motley Fool has a clear and concise disclosure policy. At the time of writing, of the companies mentioned above, Bruce Jackson owned shares in IPH and Altium and Andrew Page owned shares in Australian Pharmaceutical Industries. The Motley Fool, its contractors and employees may own shares in the companies listed above, and those positions may change at any time.

All returns cited are hypothetical and based on the percentage change between the stock price at the time of recommendation and the current or sell price (if the position has been closed) at the time of publication. Brokerage, taxes and any other associated costs are not taken into account. Please remember that investments can go up and down. Past performance is not necessarily indicative of future returns. Performance figures are not intended to be a forecast and The Motley Fool does not guarantee the performance of, or returns on any investment. Any money back guarantee is strictly limited to the subscription price paid for the product. Any and all advice contained in the above content is general advice that has not taken into account your personal circumstances. Please refer to our Financial Services Guide for more information.

Please read our Privacy Statement and Terms of Service.

© 2009 – 2017 The Motley Fool Australia Pty Ltd. All rights reserved.